Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 464-469

  Yang, Sae Jeong ^a   Hong, Ho Cheol ^a   Choi, Hae Yoon ^a   Yoo, Hye Jin ^a   Cho, Geum Ju ^a   Hwang, Teak Geun ^a   Baik, Sei Hyun ^a   Choi, Dong Seop ^a   Kim, Seon Mi ^a   Choi, Kyung Mook ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; EXERCISE; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RESISTANCE TRAINING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ALPHA-2-HS-GLYCOPROTEIN; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, LDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MIDDLE AGED; OBESITY;

EID: 80052522462     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04078.x     Document Type: Article

References (35)

1. Kliewer, S.A., &, Mangelsdorf, D.J., (2010) Fibroblast growth factor 21: from pharmacology to physiology. American Journal of Clinical Nutrition, 91, 254S-257S.
2. Nishimura, T., Nakatake, Y., Konishi, M., et al. (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochimica et Biophysica Acta, 1492, 203-206. (Pubitemid 30349198)
3. Kharitonenkov, A., Shiyanova, T.L., Koester, A., et al. (2005) FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation, 115, 1627-1635. (Pubitemid 40814671)
4. Kharitonenkov, A., Wroblewski, V.J., Koester, A., et al. (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 148, 774-781. (Pubitemid 46143178)
5. Wente, W., Efanov, A.M., Brenner, M., et al. (2006) Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes, 55, 2470-2478. (Pubitemid 44871147)
6. Zhang, X., Yeung, D.C., Karpisek, M., et al. (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 57, 1246-1253.
7. Chavez, A.O., Molina-Carrion, M., Abdul-Ghani, M.A., et al. (2009) Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care, 32, 1542-1546.
8. Stefan, N., Hennige, A.M., Staiger, H., et al. (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 29, 853-857. (Pubitemid 44115306)
9. Ix, J.H., Shlipak, M.G., Brandenburg, V.M., et al. (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation, 113, 1760-1767. (Pubitemid 43958469)
10. Ix, J.H., Wassel, C.L., Kanaya, A.M., et al. (2008) Fetuin-A and incident diabetes mellitus in older persons. JAMA, 300, 182-188. (Pubitemid 351969302)
11. Weikert, C., Stefan, N., Schulze, M.B., et al. (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation, 118, 2555-2562.
12. WHO (2000) The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limit, Sydney, Australia.
13. Lee, S.Y., Park, H.S., Kim, D.J., et al. (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Research and Clinical Practice, 75, 72-80. (Pubitemid 44856015)
14. Kim, S.M., Lee, J., Ryu, O.H., et al. (2005) Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clinical Endocrinology (Oxf), 63, 594-598. (Pubitemid 41626757)
15. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
16. Zieman, S.J., Melenovsky, V., &, Kass, D.A., (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 932-943. (Pubitemid 40627836)
17. Laurent, S., Boutouyrie, P., Asmar, R., et al. (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension, 37, 1236-1241. (Pubitemid 34163575)
18. Imanishi, R., Seto, S., Toda, G., et al. (2004) High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertension Research, 27, 71-78. (Pubitemid 38325177)
19. Agabiti-Rosei, E., Porteri, E., &, Rizzoni, D., (2009) Arterial stiffness, hypertension, and rational use of nebivolol. Vascular Health and Risk Management, 5, 353-360.
20. Choi, K.M., Lee, K.W., Seo, J.A., et al. (2004) Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. Diabetes Research and Clinical Practice, 66, 57-61. (Pubitemid 39201372)
21. Nakanishi, N., Shiraishi, T., &, Wada, M., (2005) Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh study. Hypertension Research, 28, 125-131. (Pubitemid 40663063)
22. Dostalova, I., Haluzikova, D., &, Haluzik, M., (2009) Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiological Research, 58, 1-7.
23. Fisher, F.M., Chui, P.C., Antonellis, P.J., et al. (2010) Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes, 59, 2781-2789.
24. Kantartzis, K., Machann, J., Schick, F., et al. (2010) The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia, 53, 882-889.
25. Hennige, A.M., Staiger, H., Wicke, C., et al. (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE, 3, e1765.
26. Fisher, E., Stefan, N., Saar, K., et al. (2009) Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circulation Cardiovascular Genetics, 2, 607-613.
27. Schafer, C., Heiss, A., Schwarz, A., et al. (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. Journal of Clinical Investigation, 112, 357-366. (Pubitemid 38063764)
28. Eraso, L.H., Ginwala, N., Qasim, A.N., et al. (2010) Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care, 33, 408-410.
29. Emoto, M., Mori, K., Lee, E., et al. (2010) Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism, 59, 873-878.
30. Lakka, T.A., &, Laaksonen, D.E., (2007) Physical activity in prevention and treatment of the metabolic syndrome. Applied Physiology, Nutrition, and Metabolism, 32, 76-88.
31. Green, D.J., Maiorana, A., O'Driscoll, G., et al. (2004) Effect of exercise training on endothelium-derived nitric oxide function in humans. Journal of Physiology, 561, 1-25. (Pubitemid 39549463)
32. Kobayashi, K., Akishita, M., Yu, W., et al. (2004) Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis, 173, 13-18. (Pubitemid 38224191)
33. Mai, K., Schwarz, F., Bobbert, T., et al. (2011) Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction. Metabolism, 60, 306-311.
34. Schultes, B., Frick, J., Ernst, B., et al. (2010) The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. Experimental and Clinical Endocrinology and Diabetes, 118, 754-756.
35. Brix, J.M., Stingl, H., Hollerl, F., et al. (2010) Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. Journal of Clinical Endocrinology and Metabolism, 95, 4877-4881.